Jie Liu, Xin-Xing Wan, Sheng-Yuan Zheng, Hui-Hong He, Md Asaduzzaman Khan, Yu-Xing Feng, Jing-Ge Xiao, Yu Chen, Xi-Min Hu, Qi Zhang, Kun Xiong
Type 1 Diabetes (T1D) is characterized by hyperglycemia, and caused by a lack of insulin secretion. At present there is no cure for T1D and patients are dependent on exogenous insulin for lifelong, which seriously affects their lives. Mesenchymal stem cells (MSCs) can be differentiated to β cell-like cells to rescue the secretion of insulin and reconstruct immunotolerance to preserve the function of islet β cells. Due to the higher proportion of children and adolescents in T1D patients, the efficacy and safety issue of the application of MSC's transplant in T1D was primarily demonstrated and identified by human clinical trials in this review...
October 10, 2023: Current Stem Cell Research & Therapy